α
AlphaScala
StocksSignalsNEWAlpha ScoreBriefingsNEWBrokers
Sign InGet Started
α
AlphaScala

Professional trading analysis with publicly tracked portfolios on TipRanks. Real trades, real data.

Markets

ForexStocksCryptoCommodities

Tools

Stock ResearchMarket SignalsMarket BriefingsAlpha ScoreHedge Funds 13FInsider BuysPolitician TradesAgentic TradingAI Broker MatcherBroker ReviewsPortfoliosFree IndicatorsBlogLearn TradingTrading Q&A

Account

Sign InDashboardNewsletterContact UsAdvertise

Legal

AboutMethodologyEditorial PolicyCorrectionsTerms of ServicePrivacy PolicyRisk Disclaimer

Risk Warning: AlphaScala provides educational content only and is not a financial advisor. Trading and investing involves substantial risk of loss and is not suitable for all investors. Past performance does not guarantee future results. You should consult a licensed financial advisor before making investment decisions. See our full risk disclaimer.

© 2026 ROGA AI LIMITED · Registered in Gibraltar · Unit G02, Eurocity, Europort Avenue, Gibraltar GX11 1AAAlphaScala – Built with data, not hype.
All Stocks/Healthcare/OMCL

OMNICELL, INC.

OMCL
HealthcareHealth Information Services Website
Signal SnapshotMarket signals →
Alpha Score
Score pending
Alpha Score appears once the required price and fundamentals data has ingested.
Daily model
Insiders
No recent signal
No recent open-market insider buying or selling is in the current rollup.
Form 4
13F Holder
D.E. Shaw
$41.31M reported position; latest action: new.
David Shaw
Latest Filing
No filing digest
Recent 10-K, 10-Q, and 8-K summaries will appear here when available.
SEC digest
Price ChartPowered by TradingView
Ask about OMCLAI research agent
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
D.E. Shaw
David Shaw
912K$41.31MNEW
Renaissance Technologies
Jim Simons (founder)
327K$14.81MNEW
Citadel
Ken Griffin
263K$11.91MNEW
Point72
Steve Cohen
144K$6.55MNEW
Marshall Wace28K$1.27MNEW
Explore all tracked funds →
About OMNICELL, INC.

Omnicell Inc. operates as a provider of medication management solutions and adherence tools within the healthcare industry. Its primary function is to optimize medication management and supply chain processes in healthcare facilities, aiming to enhance safety and efficiency. The company offers automated dispensing systems, pharmacy automation equipment, and software solutions tailored for acute care hospitals, long-term care settings, and other healthcare facilities. Notable features of Omnicell’s offerings include their ability to reduce medication errors, improve workflow efficiency, and facilitate better inventory management. Omnicell plays a significant role in the healthcare sector, impacting hospitals' and pharmacies' ability to comply with stringent regulatory standards while maintaining high levels of patient care. By integrating advanced technologies such as robotics, analytics, and cloud-based solutions, Omnicell supports the digital transformation of medication management, addressing challenges associated with manual processes and medication non-adherence. The company’s market significance is evident as it continually adapts to the evolving needs of healthcare providers, ensuring effective medication administration and promoting patient safety on a global scale.

CEO
Mr. Randall A. Lipps
Employees
3,580
Quick Facts
Exchange–
SectorHealthcare
IndustryHealth Information Services
Market Cap–
Popular Stocks
AAPL
Apple Inc.
MSFT
Microsoft Corporation
NVDA
NVIDIA Corporation
AMZN
Amazon.com Inc.
GOOGL
Alphabet Inc. Class A
GOOG
Alphabet Inc. Class C
META
Meta Platforms Inc.
TSLA
Tesla Inc.
Key Dates

Earnings calendar coming soon. Subscribe to get notified when OMCL reports next.

Get earnings alerts →